Resveratrol induces vasorelaxation of mesenteric and uterine arteries from female guinea-pigs

被引:84
作者
Naderali, EK
Doyle, PJ
Williams, G
机构
[1] Univ Liverpool, Dept Med, Clin Dept, Diabet & Endocrinol Res Unit, Liverpool L69 3GA, Merseyside, England
[2] Novo Nordisk AS, DK-2880 Bagsvaerd, Denmark
关键词
conductive arteries; female guinea-pigs; resistance arteries; resveratrol;
D O I
10.1042/CS19990303
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Naturally occurring hydroxystilbenes have been shown to induce vasorelaxation. Here, we studied the mechanism of resveratrol-induced vasorelaxation in different types of blood vessels, namely mesenteric (resistance) and main uterine (conductance) arteries, from female guinea-pigs on day 7 and day 15 of the oestrous cycle. Resveratrol (5-70 mu mol/l) induced concentration-dependent relaxation of both mesenteric and uterine arteries preconstricted with either noradrenaline (NA; 10 mu mol/l) or KCl (125 mmol/l). Resveratrol was 2-fold more potent in inducing relaxation of mesenteric arteries than of uterine arteries. Its effects on uterine arteries from both day-7 and day- 15 guinea-pigs were similar, irrespective of the constrictor used, but it was significantly (P < 0.01) more potent in inducing relaxation of mesenteric arteries contracted with NA compared with those constricted with KCl. In day-7 arteries precontracted with NA, N-G-nitro-L-arginine methyl ester (L-NAME; 10 mu mol/l) had no effects on the time course of resveratrol-induced vasorelaxation in either mesenteric or uterine arteries. However, indomethacin (50 mu mol/l) significantly (P < 0.05) potentiated resveratrol's effect on mesenteric, but nor uterine, arteries. Indomethacin had no effect on resveratrol-induced vasorelaxation of arteries contracted with KCl, whereas L-NAME significantly (P < 0.05) reduced the effects of resveratrol on uterine, bur not on mesenteric, arteries. In day-15 arteries, L-NAME significantly (P < 0.01) attenuated the effects of resveratrol on mesenteric arteries contracted with NA. Indomethacin had no effect on resveratrol activity. This study indicates that: (a) the effect of resveratrol on resistance arteries is greater than that on conductance arteries; (b) the effects of resveratrol are not mediated via prostanoids, but NO may play a role; and (c) the stage of the oestrous cycle has no influence on resveratrol-induced vasorelaxation.
引用
收藏
页码:537 / 543
页数:7
相关论文
共 31 条
[1]   Mechanism of endothelial nitric oxide-dependent vasorelaxation induced by wine polyphenols in rat thoracic aorta [J].
Andriambeloson, E ;
Stoclet, JC ;
Andriantsitohaina, R .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1999, 33 (02) :248-254
[2]   Nitric oxide production and endothelium-dependent vasorelaxation induced by wine polyphenols in rat aorta [J].
Andriambeloson, E ;
Kleschyov, AL ;
Muller, B ;
Beretz, A ;
Stoclet, JC ;
Andriantsitohaina, R .
BRITISH JOURNAL OF PHARMACOLOGY, 1997, 120 (06) :1053-1058
[3]   Interaction of transresveratrol with plasma lipoproteins [J].
Belguendouz, L ;
Frémont, L ;
Gozzelino, MT .
BIOCHEMICAL PHARMACOLOGY, 1998, 55 (06) :811-816
[4]   ROLE OF CYCLIC-AMP IN THE INHIBITION OF HUMAN-PLATELET AGGREGATION BY QUERCETIN, A FLAVONOID THAT POTENTIATES THE EFFECT OF PROSTACYCLIN [J].
BERETZ, A ;
STIERLE, A ;
ANTON, R ;
CAZENAVE, JP .
BIOCHEMICAL PHARMACOLOGY, 1982, 31 (22) :3597-3600
[5]   INHIBITION OF HUMAN-PLATELET CYCLIC-AMP PHOSPHODIESTERASE AND OF PLATELET-AGGREGATION BY A HEMISYNTHETIC FLAVONOID, AMENTOFLAVONE HEXAACETATE [J].
BERETZ, A ;
BRIANCONSCHEID, F ;
STIERLE, A ;
CORRE, G ;
ANTON, R ;
CAZENAVE, JP .
BIOCHEMICAL PHARMACOLOGY, 1986, 35 (02) :257-262
[6]  
Bertelli A., 1996, INT J TISSUE REACT, V17, P1
[7]   Resveratrol content of some wines obtained from dried Valpolicella grapes: Recioto and Amarone [J].
Celotti, E ;
Ferrarini, R ;
Zironi, R ;
Conte, LS .
JOURNAL OF CHROMATOGRAPHY A, 1996, 730 (1-2) :47-52
[8]  
Chen CK, 1996, GEN PHARMACOL-VASC S, V27, P363
[9]   Effect of red wine on endothelium-dependent relaxation in rabbits [J].
Cishek, MB ;
Galloway, MT ;
Karim, M ;
German, JB ;
Kappagoda, CT .
CLINICAL SCIENCE, 1997, 93 (06) :507-511
[10]  
DUARTE J, 1983, GEN PHARMACOL, V4, P857